Ebola: The making of a $1 billion drug
October 28, 2014 at 10:07 AM EDT
Drug makers stand to make $1 billion in federal contracts to develop stockpiles of Ebola vaccines and treatments for the U.S. government, says investment bank Credit Suisse.
